HK1202803A1 - Antigens and vaccines directed against human enteroviruses - Google Patents

Antigens and vaccines directed against human enteroviruses

Info

Publication number
HK1202803A1
HK1202803A1 HK15103419.0A HK15103419A HK1202803A1 HK 1202803 A1 HK1202803 A1 HK 1202803A1 HK 15103419 A HK15103419 A HK 15103419A HK 1202803 A1 HK1202803 A1 HK 1202803A1
Authority
HK
Hong Kong
Prior art keywords
antigens
directed against
against human
vaccines directed
human enteroviruses
Prior art date
Application number
HK15103419.0A
Other languages
English (en)
Chinese (zh)
Inventor
‧卡多薩
‧加米盧丁
‧哈米德
Original Assignee
Sentinext Therapeutics Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinext Therapeutics Sdn Bhd filed Critical Sentinext Therapeutics Sdn Bhd
Publication of HK1202803A1 publication Critical patent/HK1202803A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32323—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32371—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK15103419.0A 2011-11-03 2015-04-08 Antigens and vaccines directed against human enteroviruses HK1202803A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2011005318 2011-11-03
PCT/IB2012/003114 WO2013098655A2 (en) 2011-11-03 2012-11-01 Antigens and vaccines directed against human enteroviruses

Publications (1)

Publication Number Publication Date
HK1202803A1 true HK1202803A1 (en) 2015-10-09

Family

ID=47215776

Family Applications (3)

Application Number Title Priority Date Filing Date
HK15103419.0A HK1202803A1 (en) 2011-11-03 2015-04-08 Antigens and vaccines directed against human enteroviruses
HK18104787.9A HK1245128A1 (zh) 2011-11-03 2018-04-12 針對人腸道病毒的抗原及疫苗
HK18111177.2A HK1251492B (zh) 2011-11-03 2018-08-30 針對人腸道病毒的疫苗

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK18104787.9A HK1245128A1 (zh) 2011-11-03 2018-04-12 針對人腸道病毒的抗原及疫苗
HK18111177.2A HK1251492B (zh) 2011-11-03 2018-08-30 針對人腸道病毒的疫苗

Country Status (16)

Country Link
US (3) US9987350B2 (ko)
EP (2) EP2773372B1 (ko)
JP (2) JP6190378B2 (ko)
KR (3) KR102002103B1 (ko)
CN (2) CN107441484A (ko)
AU (1) AU2012360168C1 (ko)
BR (1) BR112014010658A2 (ko)
CA (1) CA2854594C (ko)
CL (1) CL2014001160A1 (ko)
HK (3) HK1202803A1 (ko)
MX (2) MX363409B (ko)
MY (1) MY172501A (ko)
PH (2) PH12014501041B1 (ko)
SG (1) SG11201401998VA (ko)
TW (2) TWI626308B (ko)
WO (1) WO2013098655A2 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI700295B (zh) * 2013-12-16 2020-08-01 馬來西亞商Ｍａｂ探索私人有限公司 對會感染人類之腸病毒具有專一性之抗體
KR20170068410A (ko) * 2014-04-29 2017-06-19 내셔날 헬스 리서치 인스티튜트 엔테로바이러스 감염증에 대항하는 아데노바이러스 벡터-기반 백신
CN111944023B (zh) * 2014-11-07 2022-08-19 普莱柯生物工程股份有限公司 一种抗o型口蹄疫的疫苗组合物及其制备方法和应用
CN106554965B (zh) * 2015-09-28 2019-08-27 斯澳生物科技（苏州）有限公司 用于制备ev71病毒样颗粒的核酸构建体和方法
CN105348391B (zh) * 2015-11-03 2019-06-28 李越希 埃可病毒6型vp1蛋白特异性抗原表位及其融合蛋白的制备、应用
CN105802923B (zh) * 2016-04-14 2019-07-16 中国科学院生物物理研究所 一种重组脊髓灰质炎病毒样颗粒及其制备方法与应用
MX2018012858A (es) * 2016-04-22 2019-07-04 Integrated Res Associates Llc Metodo mejorado para producir particulas similares a virus.
WO2018066999A2 (en) 2016-10-07 2018-04-12 Sentinext Therapeutics Sdn Bhd Chimeric enterovirus virus-like particles
WO2018067000A1 (en) 2016-10-07 2018-04-12 Sentinext Therapeutics Sdn Bhd Expression cassettes and methods for obtaining enterovirus virus-like particles
KR102091372B1 (ko) 2017-02-28 2020-05-27 대한민국 엔테로바이러스 71형 불활화 백신 및 이의 용도
CN108624601B (zh) * 2017-03-17 2023-08-11 中国科学院上海巴斯德研究所 酵母表达的柯萨奇病毒a10病毒样颗粒及其应用
CN108152511B (zh) * 2017-12-20 2019-01-04 广州瑞辉生物科技股份有限公司 柯萨奇A16病毒抗原多肽及其IgM抗体检测试剂盒
CN108424881B (zh) * 2018-03-23 2021-07-27 中国食品药品检定研究院 一株肠道病毒68型及其在制备ev-d68型感染动物中的应用
JP7022335B2 (ja) 2018-05-16 2022-02-18 住友電装株式会社 コネクタ
JP7001963B2 (ja) 2018-05-16 2022-01-20 住友電装株式会社 コネクタ
WO2020067027A1 (ja) * 2018-09-28 2020-04-02 一般財団法人阪大微生物病研究会 Ｖｌｐ発現ｃｈｏ細胞株の構築
CN110045105B (zh) * 2018-11-09 2022-04-26 广州市妇女儿童医疗中心 柯萨奇A16病毒IgA抗体量子点免疫荧光层析试纸条及试剂盒
EP3897691A4 (en) * 2018-12-21 2022-08-31 The Regents of the University of California IL-10 VACCINES AND THEIR USES
CN110684781B (zh) * 2019-06-24 2021-05-28 四川农业大学 一种3型鸭甲肝病毒突变基因isa-a117c-t1142a及构建方法
CN112048004B (zh) * 2020-07-14 2021-10-22 桂林医学院 一种柯萨奇病毒b5型病毒样颗粒、其制备方法及应用
WO2022070210A1 (en) * 2020-09-29 2022-04-07 Bharat Biotech International Limited Stable formulations of low abundance enteroviruses vaccines and process of manufacture thereof
CN114107392A (zh) * 2021-11-22 2022-03-01 昆明理工大学 一种cvb5病毒类病毒样颗粒的制备方法
CN115010813B (zh) * 2022-05-19 2024-04-05 桂林医学院 一种肠道病毒71型病毒样颗粒、其制备方法及应用
US11826418B1 (en) 2023-01-06 2023-11-28 King Faisal University Virus-like particle (VLP)-based vaccine against CVB4
CN117456519B (zh) * 2023-12-22 2024-03-12 江西科益高新技术有限公司 一种用于工控安全的仿真光电靶标装置及其仿真方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8102740A (nl) 1981-06-05 1983-01-03 Nederlanden Staat Virusvaccins en werkwijze ter bereiding daarvan.
US7968086B2 (en) 2001-11-26 2011-06-28 Duke University Genetically stable enterovirus expression vector with replaced stem loop VI
US20050112095A1 (en) * 2002-07-09 2005-05-26 Tsu-An Hsu Internal ribosome entry sites for recombinant protein expression
EP1479761A1 (en) * 2003-05-21 2004-11-24 PrimaGen Holding B.V. New enterovirus, vaccines, medicaments and diagnostic kits
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
JP5602366B2 (ja) * 2005-11-01 2014-10-08 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー β−プロピオラクトン処理による低レベルの残存細胞ＤＮＡを含む細胞由来のウイルスワクチン
WO2008005777A2 (en) * 2006-06-30 2008-01-10 Novavax, Inc. Methods of enhancing protein incorporation into virus like particles
CN102197136B (zh) * 2008-08-28 2016-09-28 诺华股份有限公司 通过终止密码子连读的多肽同种型的细胞表面展示
US8663951B2 (en) * 2009-01-09 2014-03-04 Academia Sinica Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system
CN101831410B (zh) 2009-03-09 2013-04-17 北京工业大学 重组肠病毒71型病毒样颗粒的制备方法
GB0918375D0 (en) 2009-10-20 2009-12-02 Animal Health Inst Construct
TWI670373B (zh) * 2011-02-08 2019-09-01 淡馬錫生命科學實驗室有限公司 用於有效率地表面呈示抗原蛋白質之新穎表現匣

Also Published As

Publication number Publication date
US9987350B2 (en) 2018-06-05
HK1245128A1 (zh) 2018-08-24
HK1251492B (zh) 2019-10-25
AU2012360168B2 (en) 2017-06-22
WO2013098655A3 (en) 2013-09-12
US20180271971A1 (en) 2018-09-27
CL2014001160A1 (es) 2014-11-03
US20150140027A1 (en) 2015-05-21
PH12014501041A1 (en) 2014-08-04
JP2014532691A (ja) 2014-12-08
AU2012360168A2 (en) 2015-04-30
KR101900460B1 (ko) 2018-11-08
CA2854594A1 (en) 2013-07-04
KR102002103B1 (ko) 2019-07-19
SG11201401998VA (en) 2014-05-29
WO2013098655A9 (en) 2013-12-19
JP2017226677A (ja) 2017-12-28
CN107441484A (zh) 2017-12-08
TWI626308B (zh) 2018-06-11
TW201333195A (zh) 2013-08-16
EP2773372A2 (en) 2014-09-10
EP3290050B1 (en) 2019-01-02
CN104093420A (zh) 2014-10-08
MX2018013782A (es) 2021-12-08
KR101782451B1 (ko) 2017-09-29
AU2012360168A1 (en) 2014-05-22
CN104093420B (zh) 2017-07-28
MX2014005315A (es) 2015-03-09
PH12014501041B1 (en) 2014-08-04
EP2773372B1 (en) 2018-12-26
US20180243400A1 (en) 2018-08-30
CA2854594C (en) 2018-08-21
AU2012360168C1 (en) 2017-09-28
JP6190378B2 (ja) 2017-08-30
WO2013098655A2 (en) 2013-07-04
KR20170109700A (ko) 2017-09-29
EP3290050A1 (en) 2018-03-07
BR112014010658A2 (pt) 2017-06-13
US10548964B2 (en) 2020-02-04
TWI571512B (zh) 2017-02-21
KR20180104201A (ko) 2018-09-19
US10555997B2 (en) 2020-02-11
KR20140096343A (ko) 2014-08-05
MY172501A (en) 2019-11-27
JP6419271B2 (ja) 2018-11-07
PH12019500289A1 (en) 2020-02-17
MX363409B (es) 2019-03-20
TW201716576A (zh) 2017-05-16

Similar Documents

Publication Publication Date Title
HK1245128A1 (zh) 針對人腸道病毒的抗原及疫苗
HK1201282A1 (en) Antibodies against human csf-1r and uses thereof csf-1r
ZA201500887B (en) Human anti-cd27 antibodies, methods and uses
HK1243344A1 (zh) 抗體製劑和方法
ZA201307641B (en) Human tissue factor antibody and uses thereof
GB2495522B (en) Surgical device and methods
HK1206249A1 (en) Human autotaxin antibodies and methods of use (autotaxin)
IL232145A (en) Preparations of pesticides and methods
HK1198940A1 (en) Vaccines for human papilloma virus and methods for using the same
ZA201407309B (en) Antigens and antigen combinations
GB201112260D0 (en) Medical device and related methods
GB201207385D0 (en) Antigens and antigen combinations
GB201207383D0 (en) Antigens and antigen combinations
GB201102236D0 (en) Inventions and therapy
GB201102216D0 (en) Inventions and therapy
GB201102208D0 (en) Inventions and therapy
GB201102238D0 (en) Inventions and therapy
GB201102210D0 (en) Inventions and therapy
GB201102212D0 (en) Inventions and therapy
GB201102215D0 (en) Inventions and therapy
GB201102227D0 (en) Inventions and therapy
GB201102221D0 (en) Inventions and therapy
GB201102222D0 (en) Inventions and therapy
GB201102226D0 (en) Inventions and therapy
GB201102234D0 (en) Inventions and therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211104